SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

ABCL is currently seeing high volatility and heavy trading volume as investors debate its long-term potential following recent clinical trial data and a significant partnership with Jazz Pharmaceuticals. The community is sharply divided between "long" shareholders who view recent price dips as an accumulation opportunity and vocal critics who argue the company has failed to deliver consistent returns over the past five years.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors monitor a critical court hearing regarding the distribution rights for its lead DMD therapy, alongside growing optimism that the FDAs recent shift toward more transparent, rare-disease-friendly reviews could pave the way for a swift, broad label approval ahead of the PDUFA date. The community is heavily focused on the potential for an injunction against its commercial partner to resolve distribution hurdles, while actively debating the impact of upcoming five-year clinical data and the broader regulatory environment on the stock's valuation.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF is trending as investors rotate into defensive, income-focused positions amid broader market uncertainty. Community discourse centers on the ETF's role as a stable portfolio anchor for long-term compounding, with active discussions regarding dividend growth consistency, reconstitution updates, and strategic buying opportunities.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to reports of a Japanese government delegation planning to explore rare-earth mining opportunities in Greenland, a region where the company controls a major stake in the Tanbreez Project. Community discussion is heavily focused on potential geopolitical tailwinds, the company's progress toward production, and active debates over the stock's valuation, share dilution, and the timing of upcoming project updates.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is facing significant downward pressure following the release of incomplete May sales data, which has exacerbated investor concerns and fueled speculation regarding competitive threats from AstraZeneca's Ultomiris. Despite the negative price action, the community is actively debating the reliability of these sales metrics and looking toward upcoming regulatory milestones, including EMA developments and the activation of the J-Code, as potential catalysts for a recovery.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx shares are currently experiencing volatility as investors weigh strong IBSRELA revenue growth against the ongoing uncertainty surrounding a CMS court ruling and management's aggressive spending strategy. While the community is debating potential M&A rumors and the long-term impact of pending legal outcomes, active traders are closely monitoring institutional volume and support levels while awaiting a definitive catalyst to break the current consolidation pattern.

Apogee Therapeutics, Inc. is a clinical stage biotechnology company. It offers treatment of atopic dermatitis (AD), ashma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded by Andrew Gottesdiener and Nimish P. Shah in 2022 and is headquartered in Waltham, MA.

Apogee Therapeutics Inc.

Apogee Therapeutics

Apogee Therapeutics is trending following a massive multi-billion dollar acquisition deal by AbbVie, which investors view as a validation of the biotech firm's immunology pipeline. Community sentiment is high, with market participants debating if the premium buyout signals a broader M&A wave for other immunology-focused companies as big pharma looks to secure high-potential, long-acting assets.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors debate whether the recent sector-wide pullback offers a compelling entry point or signals further downside, with the community actively analyzing management milestones like IM-3 integration against broader concerns of sector rotation and volatility. Traders are focused on upcoming NASA lunar mission updates as a potential catalyst to stabilize price action following a significant correction from recent highs.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors weigh aggressive government backing, including major CHIPS Act funding and site selection for a massive magnet manufacturing facility, against volatility from the broader rare earth sector and an ongoing legal dispute with MP Materials. Community members are actively debating whether these fundamental tailwinds and defense-critical supply chain integration represent a long-term structural breakout or a high-beta cyclical trade.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased investor focus as analyst upgrades and a pivot toward defensive sector rotation drive positive momentum. The community is actively debating the stock's potential for a long-term recovery to historical highs, with many investors highlighting their strategy of accumulating shares during dips to benefit from consistent dividends and the company's dominant market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the Vanguard Information Technology Index Fund ETF Shares (VGT)?

US-Iran Deal Hopes: ETFs to Buy & Avoid

US-Iran deal hopes may ease oil prices, curb inflation and lift risk appetite. Here are some ETFs that could win, and those that may lag.

Here's How Much $1000 Invested In Vanguard Information Tech ETF 20 Years Ago Would Be Worth Today

Vanguard Information Tech ETF (NYSE:VGT) has outperformed the market over the past 20 years by 7.07% on an annualized basis producing an average annual return of 16.25%. Currently, Vanguard Information Tech ETF has aread more...

Jim Paulsen Sounds Alarm On US Stocks, Sees Correction Signs ‘Ripening’ – ‘My Enthusiasm For Stocks Is Waning…’

Equity

Veteran economist Jim Paulsen said he is growing increasingly cautious on U.S. stocks but has played down the chances of a recession in the near term.

Bitcoin’s Rout Reignites The 'Digital Gold' Debate – Here’s What Analysts Are Saying

Bitcoin crashed to near four-month lows on Thursday, while spot gold prices rose nearly 1%.

AI Stock Jumps 3% After-Hours — Founder Siebel Returns As CEO With $69M Cash Injection

The stock climbed despite another quarter of revenue declines and operating losses year over year.


Tech ETFs to Buy as NVIDIA Sets Foot Into PC Market via New AI Chip

Tech ETFs with heavy exposure to NVDA gain attention, as the company enters the PC market with its RTX Spark AI superchip.

APPS Stock Soars 53%, On Track For Best Single-Day Gains In 11 Months — Why Did BofA Turn Bullish On Digital Turbine?

Digital Turbine reported earnings per share of $0.16 in Q4 on revenue of $143 million, while Wall Street expected an EPS of $0.09 on revenue of $133 million.

Chamath Palihapitiya Rips Into Cloudflare CEO's Layoff Memo: 'I Think You Did A Horrible Job'

Palihapitiya added that Matthew Prince’s memo has reduced employees to a label, while saying that he couldn’t have written a worse one.

OUST Stock Hits 52-Week High Today — What Is The Counter-Drone Partnership With ARGUS About?

ARGUS plans to use Ouster's sensors to improve non-kinetic counter-drone operations, particularly in environments where traditional interception methods are impractical.

Vanguard World Fund - Vanguard Information Technology ETF

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

VGTVanguard Information Technology ETF

Latest VGT News